je.st
news
Tag: johnson johnsons
Johnson & Johnson's Outlook
2016-03-29 13:57:34| Biotech - Topix.net
It's time to take a look at Johnson & Johnson's valuation again, because I like to review all of my long-term stock holdings at least once per year. Currently, I am not holding a whole lot of value in the US stock market.
Tags: johnson
outlook
johnsons
johnson johnsons
Johnson & Johnson's Growing Drug Dependency Makes The Business More Unpredictable
2016-03-29 01:23:06| Biotech - Topix.net
J&J's strong Pharma performance over the past few years, coupled with tepid growth in Consumer Healthcare and Medical Devices, indicates a shift in basic revenue structure. The more they succeed at Pharma and lose growth in Consumer Healthcare, the greater their risk of unstable revenue growth.
Tags: business
makes
growing
drug
Johnson & Johnson's Stelara Succeeds In Phase III Crohn's Disease Trial
2015-10-19 19:30:37| Food - Topix.net
Johnson & Johnson's Stelara was significantly better than placebo at inducing clinical response and remissions in patients with moderate to severe Crohn's disease, according to data from a late stage trial, providing ammunition for a potential expanded approval of the medicine. Stelara, a biotech medicine that blocks inflammation, is approved to treat the skin condition scaly plaque psoriasis and a type of arthritis associated with psoriasis.
Johnson & Johnson's New Drug Invega Trinza Will Help Drive Pharma Sales
2015-06-30 07:37:38| Biotech - Topix.net
Johnson & Johnson is launching the new Invega Trinza antipsychotic drug, which only needs to be taken four times a year. Together with the highly successful Invega Sustenna, Invega Trinza can help drive sales of J&J's pharma segment, which was the best performer of the company in Q1 2015.
Tags: sales
drive
drug
johnson
Cardinal Health offers to buy Johnson & Johnson's Cordis business for about $1.94 billion
2015-03-02 16:33:27| Biotech - Topix.net
Cardinal Health is offering to buy a unit of Johnson & Johnson that makes heart devices for approximately $1.94 billion. Johnson & Johnson's Cordis business, which is based in Fremont, California, had 2014 revenue of about $780 million.
Tags: business
buy
health
offers